Condition: Mesenchymal Chondrosarcoma · Sponsor: Italian Sarcoma Group
Prospective, uncontrolled, investigator-initiated, phase II clinical study to explore the activity of trabectedin in a population of patients aged ≥16 years with progressive, advanced (locally advanced or metastatic)
This description comes directly from the study's public registry record.
Silvia Stacchiotti, MD · 39022390 · silvia.stacchiotti@istitutotumori.mi.it
Always discuss trial participation with your own doctor first.
| Nuovo Ospedale di Prato | Prato, Firenze, Italy | Recruiting |
| Policlinico Universitario Campus Biomedico | Roma, RM, Italy | Not Yet Recruiting |
| Fondazione del Piemonte per l'Oncologia IRCC Candiolo | Candiolo, Torino, Italy | Recruiting |
| Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors | Bologna, Italy | Recruiting |
| Fondazione IRCSS Istituto Nazionale dei Tumori | Milan, Italy | Recruiting |
| Ospedale Giaccone | Palermo, Italy | Recruiting |
| Istituti Fisioterapici Ospitalieri - Ospedale Regina Elena | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04305548